CDT

NASDAQ 已收盘

CDT Equity

0.23 USD
▼-0.04-13.89%
盘后 0.24 +4.35%
2026-11-20
市值
$12.93K
市盈率
—
EPS
-468.58
股息率
—
52 周区间
0.22 – 291,250.00
成交量
853.74K
Beta
1.69
目标价
—
52W 低 0.2252W 高 291,250.00
价格走势

公司简介

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also ...